ARCHIVES

Telatinib Demonstrates Positive Results in First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile

November 23, 1997

Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.

December 10, 2004

Breast Cancer Coalition Seeks Continued DOD Funding For Research

July 2, 1993

AACR, Kellogg’s Co. Sponsor Award

January 5, 1996

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

NCI Getting a Lot For a Little Money It Spends Overseas, International Program Director Says

June 17, 1977